Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in mice

This publication has 32 references indexed in Scilit:

• Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate
  Biochemical Pharmacology, 1992
• Thymidylate synthase from untreated human colorectal cancer and colonic mucosa: Enzyme activity and inhibition by 5-fluoro-2′-deoxyuridine-5′-monophosphate
  European Journal of Cancer and Clinical Oncology, 1991
• Effects of the combination of acivicin and cis-diammine-dichloroplatinum(II) on thymidylate synthesis of A549 lung cancer cells
  Biochemical and Biophysical Research Communications, 1989
• The Role of Drug Sequence in Therapeutic Selectivity of the Combination of 5-Fluorouracil and Cis-Platin
  Selective Cancer Therapeutics, 1989
• Comparative behavioral toxicity of four sulfhydryl radioprotective compounds in mice: WR-2721, cysteamine, diethyldithiocarbamate, and N-acetylcysteine
  Pharmacology & Therapeutics, 1988
• Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy
  Pharmacology & Therapeutics, 1988
• The time course of radioprotection by WR 2721 in mouse skin
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982
• The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenografts
  European Journal of Cancer and Clinical Oncology, 1982
• Interactions of platinum complexes with the essential and nonessential sulfhydryl groups of thymidylate synthetase
  Biochemistry, 1977
• S-[2-(.omega.-Aminoalkylamino)ethyl] dihydrogen phosphorothioates and related compounds as potential antiradiation agents
  Journal of Medicinal Chemistry, 1969